NIKKEI 225
26,402.84 -508.36 (-1.89%) HANG SENG
20,149.42 -494.86 (-2.40%) CRUDE OIL
110.30 +0.71 (+0.65%) GOLD FUTURES
1,811.50 -4.40 (-0.24%) DOW
31,490.07 -1,164.52 (-3.57%) BTC-GBP
23,649.83 -679.27 (-2.79%)
Galapagos NV (GLPG.AS)
| Previous close | 55.24 |
| Open | 55.22 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 53.58 - 55.92 |
| 52-week range | 41.30 - 66.86 |
| Volume | |
| Avg. volume | 280,968 |
| Market cap | 3.519B |
| Beta (5Y monthly) | 0.30 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.71 |
| Earnings date | 24 Feb 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 63.27 |
- Zacks
Is Galapagos (GLPG) Outperforming Other Medical Stocks This Year?
Here is how Galapagos NV (GLPG) and Halozyme Therapeutics (HALO) have performed compared to their sector so far this year.
- Zacks
Perrigo (PRGO) Q1 Earnings Miss, Margins Hurt by Higher Costs
Perrigo (PRGO) reports mixed first-quarter 2022 results. Sales of cough/cold products continue the strong rebound during the reported quarter. Costs headwinds offset volume and price growth.
- Globe Newswire
Galapagos creates new subscription right plans
Mechelen, Belgium; 6 May 2022, 22.01 CET; regulated information –– Galapagos NV (Euronext & NASDAQ: GLPG) announced today that its board of directors created 2,326,025 subscription rights under new subscription right plans for the benefit of certain members of the personnel of the company and its subsidiaries. On 6 May 2022, the board of directors of Galapagos approved “Subscription Right Plan 2022 BE”, intended for members of personnel of the company and its Belgian subsidiary, “Subscription Ri
